HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 258 filers reported holding HAEMONETICS CORP in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $80,444 | +20.2% | 898 | +14.2% | 0.02% | +18.8% |
| Q2 2023 | $66,921 | +25.2% | 786 | +21.7% | 0.02% | +14.3% |
| Q1 2023 | $53,457 | +51.4% | 646 | +43.9% | 0.01% | +40.0% |
| Q4 2022 | $35,313 | +76.6% | 449 | +70.1% | 0.01% | +66.7% |
| Q3 2022 | $20,000 | +17.6% | 264 | +3.5% | 0.01% | +20.0% |
| Q2 2022 | $17,000 | +6.2% | 255 | 0.0% | 0.01% | +25.0% |
| Q1 2022 | $16,000 | +23.1% | 255 | +1.6% | 0.00% | +33.3% |
| Q4 2021 | $13,000 | -35.0% | 251 | -9.7% | 0.00% | -50.0% |
| Q3 2021 | $20,000 | +17.6% | 278 | +4.1% | 0.01% | +20.0% |
| Q2 2021 | $17,000 | +6.2% | 267 | +88.0% | 0.01% | 0.0% |
| Q1 2021 | $16,000 | +433.3% | 142 | +294.4% | 0.01% | +400.0% |
| Q1 2018 | $3,000 | +50.0% | 36 | +12.5% | 0.00% | 0.0% |
| Q4 2017 | $2,000 | +100.0% | 32 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 32 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 32 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 32 | +10.3% | 0.00% | – |
| Q4 2016 | $1,000 | – | 29 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |